Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 3,750,000 | 3,200,000 | -550,000 | $132.71M | $117.02M | 6.64% | -$15.69M |
| Spyre Therapeutics, Inc.(SYRE) | 1,279,134 | 1,279,134 | 0 | $113.56M | $113.88M | 6.46% | +$319.8K |
| Erasca, Inc.(ERAS) | 5,250,000 | 5,590,600 | +340,600 | $96.18M | $81.96M | 4.65% | -$14.22M |
| First Tracks Biotherapeutics | 2,032,012 | 2,080,000 | +47,988 | $40.88M | $73.72M | 4.18% | +$32.83M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,595,000 | 1,900,374 | +305,374 | $96.27M | $70.67M | 4.01% | -$25.60M |
| Insmed Incorporated(INSM) | 650,000 | 564,251 | -85,749 | $69.30M | $64.40M | 3.65% | -$4.90M |
| Alkermes plcSHS(ALKS) | 1,125,000 | 1,565,000 | +440,000 | $58.94M | $63.41M | 3.60% | +$4.47M |
| Oruka Therapeutics, Inc.(ORKA) | 590,000 | 600,000 | +10,000 | $56.15M | $49.97M | 2.83% | -$6.18M |
| Avalo Therapeutics, Inc.(AVTX) | 2,900,000 | 3,244,861 | +344,861 | $53.59M | $49.74M | 2.82% | -$3.85M |
| Cytokinetics, Incorporated(CYTK) | 550,000 | 750,000 | +200,000 | $46.85M | $49.43M | 2.80% | +$2.58M |
| Revolution Medicines, Inc.(RVMD) | 250,000 | 225,000 | -25,000 | $46.82M | $46.18M | 2.62% | -$636.5K |
| Praxis Precision Medicines, Inc.(PRAX) | 185,000 | 155,000 | -30,000 | $61.94M | $45.14M | 2.56% | -$16.80M |
| Belite Bio, IncADS(BLTE) | 165,000 | 242,088 | +77,088 | $25.41M | $41.11M | 2.33% | +$15.70M |
| Celldex Therapeutics, Inc.(CLDX) | 700,000 | 1,160,499 | +460,499 | $26.05M | $37.61M | 2.13% | +$11.56M |
| ABIVAX Société AnonymeADS(ABVX) | 330,000 | 330,000 | 0 | $43.98M | $32.68M | 1.85% | -$11.30M |
| Dianthus Therapeutics, Inc.(DNTH) | 400,000 | 350,000 | -50,000 | $38.99M | $30.82M | 1.75% | -$8.17M |
| Odyssey Therapeutics Inc | 766,346 | 1,260,000 | +493,654 | $14.34M | $28.00M | 1.59% | +$13.66M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 150,000 | 425,000 | +275,000 | $12.23M | $27.82M | 1.58% | +$15.59M |
| Trevi Therapeutics, Inc.(TRVI) | 1,800,172 | 1,800,172 | 0 | $33.57M | $25.78M | 1.46% | -$7.79M |
| Ovid Therapeutics Inc.(OVID) | 10,144,562 | 10,144,562 | 0 | $27.29M | $25.26M | 1.43% | -$2.03M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 2,497,864 | 2,527,384 | +29,520 | $19.31M | $24.97M | 1.42% | +$5.66M |
| Lexeo Therapeutics, Inc.(LXEO) | 5,807,611 | 7,245,611 | +1,438,000 | $27.03M | $24.49M | 1.39% | -$2.54M |
| Protagonist Therapeutics Inc | 172,125 | 172,125 | 0 | $21.10M | $24.25M | 1.38% | +$3.15M |
| Nurix Therapeutics, Inc.(NRIX) | 967,620 | 967,620 | 0 | $23.47M | $22.94M | 1.30% | -$532.2K |
| Omeros CorporationNOTE 9 500 6 1(OMER) | 0 | 0 | 0 | $12.18M | $21.21M | 1.20% | +$9.02M |
| Vogenx Inc | 0 | 915,000 | +915,000 | $0 | $20.85M | 1.18% | +$20.85M |
| Mineralys Therapeutics, Inc.(MLYS) | 750,000 | 750,000 | 0 | $20.23M | $18.85M | 1.07% | -$1.39M |
| Tyra Biosciences, Inc.(TYRA) | 200,012 | 850,000 | +649,988 | $6.39M | $18.59M | 1.05% | +$12.20M |
| Sutro Biopharma, Inc.(STRO) | 1,172,487 | 1,152,487 | -20,000 | $38.93M | $18.57M | 1.05% | -$20.36M |
| Travere Therapeutics, Inc.(TVTX) | 300,000 | 300,000 | 0 | $17.04M | $17.66M | 1.00% | +$621.0K |
| Alto Neuroscience, Inc.(ANRO) | 850,000 | 643,343 | -206,657 | $22.43M | $16.42M | 0.93% | -$6.01M |
| Arvinas, Inc.(ARVN) | 0 | 2,050,000 | +2,050,000 | $0 | $15.86M | 0.90% | +$15.86M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,650,000 | 1,716,320 | +66,320 | $10.91M | $15.62M | 0.89% | +$4.71M |
| Relay Therapeutics, Inc.(RLAY) | 1,050,000 | 850,000 | -200,000 | $19.65M | $15.34M | 0.87% | -$4.30M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 40,000 | 30,000 | -10,000 | $21.48M | $15.12M | 0.86% | -$6.36M |
| Cullinan Therapeutics, Inc.(CGEM) | 875,760 | 875,760 | 0 | $15.95M | $13.44M | 0.76% | -$2.50M |
| Savara Inc.(SVRA) | 2,512,153 | 2,512,153 | 0 | $15.47M | $12.96M | 0.74% | -$2.51M |
| Hemab Therapeutics Hldgs Inc | 138,030 | 420,000 | +281,970 | $5.07M | $12.95M | 0.73% | +$7.88M |
| Cogent Biosciences, Inc.NOTE 1 625 11 1(COGT) | 0 | 0 | 0 | $13.65M | $12.05M | 0.68% | -$1.60M |
| Climb Bio, Inc.(CLYM) | 972,000 | 972,000 | 0 | $12.67M | $11.15M | 0.63% | -$1.53M |
| ImmunityBio, Inc.(IBRX) | 0 | 1,180,000 | +1,180,000 | $0 | $11.14M | 0.63% | +$11.14M |
| Beam Therapeutics Inc.(BEAM) | 0 | 450,000 | +450,000 | $0 | $11.00M | 0.62% | +$11.00M |
| Perspective Therapeutics, Inc.(CATX) | 4,214,582 | 3,988,744 | -225,838 | $14.37M | $10.97M | 0.62% | -$3.40M |
| Jade Biosciences Inc | 840,350 | 760,350 | -80,000 | $18.67M | $10.68M | 0.61% | -$7.99M |
| Prelude Therapeutics Incorporated(PRLD) | 0 | 2,600,000 | +2,600,000 | $0 | $10.17M | 0.58% | +$10.17M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 100,000 | 175,000 | +75,000 | $5.45M | $9.68M | 0.55% | +$4.23M |
| Veradermics, Incorporated(MANE) | 100,000 | 79,400 | -20,600 | $12.29M | $9.63M | 0.55% | -$2.67M |
| Establishment Labs Holdings Inc.(ESTA) | 148,013 | 149,779 | +1,766 | $12.70M | $9.61M | 0.55% | -$3.09M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 98,999 | 300,000 | +201,001 | $1.78M | $8.73M | 0.50% | +$6.95M |
| Korsana Biosciences Inc | 0 | 263,106 | +263,106 | $0 | $8.42M | 0.48% | +$8.42M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 5,543,936 | 4,970,074 | -573,862 | $10.31M | $8.25M | 0.47% | -$2.06M |
| Vera Therapeutics, Inc.CL A(VERA) | 250,000 | 250,000 | 0 | $10.73M | $8.07M | 0.46% | -$2.65M |
| Damora Therapeutics Inc | 0 | 375,000 | +375,000 | $0 | $7.98M | 0.45% | +$7.98M |
| Research Alliance Corp IiiCL A | 370,000 | 735,538 | +365,538 | $3.96M | $7.97M | 0.45% | +$4.01M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 84,900 | 105,000 | +20,100 | $6.29M | $7.80M | 0.44% | +$1.50M |
| Celcuity IncNOTE 0 250 8 0 | 0 | 0 | 0 | $2.28M | $7.75M | 0.44% | +$5.47M |
| IDEAYA Biosciences, Inc.(IDYA) | 400,000 | 200,000 | -200,000 | $14.91M | $7.68M | 0.44% | -$7.22M |
| Anteris Technologies Global Corp.(AVR) | 912,397 | 912,397 | 0 | $8.99M | $7.09M | 0.40% | -$1.90M |
| Aktis Oncology, Inc.(AKTS) | 0 | 350,000 | +350,000 | $0 | $6.81M | 0.39% | +$6.81M |
| Enliven Therapeutics Inc | 500,000 | 148,000 | -352,000 | $25.38M | $6.78M | 0.38% | -$18.59M |
| Newamsterdam Pharma Company ORDINARY SHARES | 275,000 | 275,000 | 0 | $9.32M | $6.69M | 0.38% | -$2.63M |
| Helix Acquisition Corp. IIICL A(HLXC) | 1,250,000 | 625,000 | -625,000 | $13.30M | $6.64M | 0.38% | -$6.66M |
| X4 Pharmaceuticals, Inc.(XFOR) | 145,000 | 2,062,500 | +1,917,500 | $677.1K | $5.98M | 0.34% | +$5.30M |
| Korro Bio, Inc.(KRRO) | 706,904 | 531,904 | -175,000 | $9.32M | $5.27M | 0.30% | -$4.05M |
| Viridian Therapeutics, Inc.(VRDN) | 250,000 | 250,000 | 0 | $4.59M | $5.15M | 0.29% | +$555.0K |
| Silence Therapeutics plcADS(SLN) | 0 | 450,000 | +450,000 | $0 | $4.92M | 0.28% | +$4.92M |
| iBio, Inc.(IBIO) | 4,007,881 | 4,130,427 | +122,546 | $7.01M | $4.87M | 0.28% | -$2.14M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,750,000 | 1,000,000 | -750,000 | $11.92M | $4.87M | 0.28% | -$7.05M |
| SAB Biotherapeutics, Inc.(SABS) | 1,525,000 | 1,525,000 | 0 | $5.95M | $4.83M | 0.27% | -$1.11M |
| Opus Genetics, Inc.(IRD) | 0 | 900,000 | +900,000 | $0 | $4.36M | 0.25% | +$4.36M |
| Faeth Therapeutics, Inc.(FTH) | 144,404 | 144,404 | 0 | $3.61M | $4.29M | 0.24% | +$684.5K |
| Equillium, Inc.(EQ) | 4,100,000 | 2,613,954 | -1,486,046 | $13.12M | $4.25M | 0.24% | -$8.87M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 350,000 | +350,000 | $0 | $4.22M | 0.24% | +$4.22M |
| Latigo Biotherapeutics Inc | 0 | 250,000 | +250,000 | $0 | $4.17M | 0.24% | +$4.17M |
| Rezolute, Inc.(RZLT) | 1,000,000 | 1,000,000 | 0 | $5.20M | $4.14M | 0.23% | -$1.06M |
| Ark Etf TrGENOMIC REV ETF GENOMIC REV ETF | 0 | 74,900 | +74,900 | $0 | $4.06M | 0.23% | +$4.06M |
| Precision BioSciences, Inc.(DTIL) | 646,576 | 646,576 | 0 | $5.08M | $4.05M | 0.23% | -$1.03M |
| Amanat Acquisition CorpCL A | 375,000 | 375,000 | 0 | $3.81M | $4.00M | 0.23% | +$195.0K |
| COMPASS Pathways plcADS(CMPS) | 301,183 | 301,183 | 0 | $4.26M | $3.75M | 0.21% | -$515.0K |
| Rainier Acquisition CorpUNIT 08 24 2031 | 0 | 364,957 | +364,957 | $0 | $3.72M | 0.21% | +$3.72M |
| MacroGenics, Inc.(MGNX) | 1,216,606 | 953,979 | -262,627 | $5.62M | $3.68M | 0.21% | -$1.94M |
| Research Alliance Corp IvCL A | 0 | 300,000 | +300,000 | $0 | $3.60M | 0.20% | +$3.60M |
| Immunovant, Inc.(IMVT) | 100,000 | 100,000 | 0 | $3.85M | $3.38M | 0.19% | -$475.0K |
| Anaptysbio Inc | 826,109 | 66,464 | -759,645 | $55.76M | $3.34M | 0.19% | -$52.42M |
| Zura Bio LimitedCL A(ZURA) | 1,464,303 | 800,000 | -664,303 | $8.64M | $3.33M | 0.19% | -$5.31M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 245,000 | 245,000 | 0 | $5.34M | $3.31M | 0.19% | -$2.04M |
| Verrica Pharmaceuticals Inc.(VRCA) | 707,338 | 688,654 | -18,684 | $4.33M | $3.30M | 0.19% | -$1.03M |
| ArriVent BioPharma, Inc.(AVBP) | 125,000 | 100,000 | -25,000 | $4.34M | $3.03M | 0.17% | -$1.31M |
| MBX Biosciences, Inc.(MBX) | 75,000 | 50,000 | -25,000 | $4.14M | $2.93M | 0.17% | -$1.21M |
| PMV Pharmaceuticals, Inc.(PMVP) | 0 | 1,750,000 | +1,750,000 | $0 | $2.92M | 0.17% | +$2.92M |
| Solid Biosciences Inc | 0 | 400,000 | +400,000 | $0 | $2.89M | 0.16% | +$2.89M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 250,000 | 250,000 | 0 | $2.75M | $2.72M | 0.15% | -$27.5K |
| Entera Bio Ltd.SHS(ENTX) | 0 | 934,412 | +934,412 | $0 | $2.72M | 0.15% | +$2.72M |
| Neumora Therapeutics, Inc.(NMRA) | 1,070,651 | 4,500,000 | +3,429,349 | $1.82M | $2.68M | 0.15% | +$862.8K |
| Tcgx Acquisition CorpCL A | 0 | 200,000 | +200,000 | $0 | $2.50M | 0.14% | +$2.50M |
| Adlai Nortye Group Ltd.ADS(ANL) | 153,847 | 153,847 | 0 | $1.77M | $2.46M | 0.14% | +$692.3K |
| Eikon Therapeutics, Inc.(EIKN) | 98,001 | 298,001 | +200,000 | $1.28M | $2.40M | 0.14% | +$1.12M |
| Jatt Iii Acquisition Corp | 0 | 211,993 | +211,993 | $0 | $2.34M | 0.13% | +$2.34M |
| Jatt Ii Acquisition Corp | 200,000 | 200,000 | 0 | $2.27M | $2.25M | 0.13% | -$23.0K |
| Spero Therapeutics, Inc.(SPRO) | 0 | 1,300,000 | +1,300,000 | $0 | $1.57M | 0.09% | +$1.57M |